Karakousis, N.D.; Chrysavgis, L.; Papatheodoridi, A.; Legaki, A.-I.; Lembessis, P.; Cholongitas, E.; Chatzigeorgiou, A.; Papatheodoridis, G.
Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation. Pathogens 2023, 12, 394.
https://doi.org/10.3390/pathogens12030394
AMA Style
Karakousis ND, Chrysavgis L, Papatheodoridi A, Legaki A-I, Lembessis P, Cholongitas E, Chatzigeorgiou A, Papatheodoridis G.
Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation. Pathogens. 2023; 12(3):394.
https://doi.org/10.3390/pathogens12030394
Chicago/Turabian Style
Karakousis, Nikolaos D., Lampros Chrysavgis, Alkistis Papatheodoridi, Aigli-Ioanna Legaki, Panagiotis Lembessis, Evangelos Cholongitas, Antonios Chatzigeorgiou, and George Papatheodoridis.
2023. "Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation" Pathogens 12, no. 3: 394.
https://doi.org/10.3390/pathogens12030394
APA Style
Karakousis, N. D., Chrysavgis, L., Papatheodoridi, A., Legaki, A. -I., Lembessis, P., Cholongitas, E., Chatzigeorgiou, A., & Papatheodoridis, G.
(2023). Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation. Pathogens, 12(3), 394.
https://doi.org/10.3390/pathogens12030394
